ClinicalTrials.Veeva

Menu

Reverse Cardiac Remodeling Among Elite Athletes After Short and Long-term Detraining

B

Bispebjerg Hospital

Status

Completed

Conditions

Arrhythmias, Cardiac
Athlete Heart

Study type

Observational

Funder types

Other

Identifiers

NCT05555849
H-21043707

Details and patient eligibility

About

Exercise has many well-documented effects in the prevention or treatment of disease, but recently some studies have raised awareness of the possible negative effects of too much exercise. In former elite endurance athletes, an increased risk of cardiac fibrosis and arrhythmias have been described. Whether exercise itself is the culprit remains to be explored.

The right cardiac ventricle can be overloaded during long-term intense exercise, due to increased volume load and possibly an increased afterload. In a subgroub of athletes the appearance with morphological and functional changes resembling an ARVC like phenotype. Furthermore, atrial fibrillation among male middle-aged athletes is up to 5 times more common compared to age-matched non-athletes. The working hypothesis of this study is that male athletes remodel more than females and that some of thise changes are already measureable early after end of elite sporting carreer.

In this prospective cohort study, of 50 elite athletes at retirement, after 3 months and thereafter yearly for five years, to determine the characteristics of remodeling of the heart focusing on the left atrial and right ventricle.

Full description

A prospective cohort study of reverse cardiac remodeling in recently retired elite athletes

Aim To explore the remodeling of the heart focusing on right ventricle and left atria as well as pulmonary circulation in elite athletes at rest and during exercise as well as the effect of short and long-term reverse remodeling after the end of a professional sporting career

Methods The investigators will initiate a 5-year longitudinal study of cardiac detraining in 50 former elite athletes.

Primary outcome Change in left atrial minimum size after three months retirement (mL)

Secondary outcome:

  • Change in left atrium (LA) function measured by strain and volume measures by echocardiography and magnetic resonance cor (MRc) after three months and the following years
  • Change in right and left ventricle size and function by echocardiography and magnetic resonance cor (MRc) after three months and the following years
  • Change in VO2max after three months and the following years
  • Change in diurnal ventricular and supraventricular ectopy and heart rate variability after three months and the following years
  • Change in blood pressure, BMI after three months and the following years
  • Change in plasma lipids and HbA1c after three months and the following years

The full list of examinations includes:

  • Baseline family history, medical and training history
  • Cardio-pulmonary exercise test
  • 24-hour Holter monitoring
  • Biochemistry
  • Cardiac MR including contrast at rest and during exercise
  • Trans thoracic echocardiography

Project organization and partners Recruitment of participants is organized in cooperation with the danish national elite sports organization (Team Danmark), Divisionsforeningen (The association of professional football clubs), and Spillerforeningen (The union of professional football players).

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years at the time of screening
  • Former elite athlete from endurance sport discipline
  • End of elite sporting career >1 year ago

Exclusion criteria

  • Any known cardiac disease
  • Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could impose the subject at significant risk, or interfere significantly with the subject's participation in the study.

Trial design

50 participants in 1 patient group

Study group, Newly retired elite athletes
Description:
Elite athletes at the time of retirement of professional career. Reinvestigated after three months and thereafter yearly.

Trial contacts and locations

1

Loading...

Central trial contact

Mikkel Aarøe, cand. med.; Hanne K Rasmusen, ph.d.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems